Retour sur lavenir.net
   SOLVAY 26.560 € (-1,56 %)     SHURGARD 25.600 € (+0,39 %)     COFINIMMO 84.100 € (+1,14 %)     SYENSQO 67.000 € (0,00 %)     ACKERMANS V.HAAREN 285.400 € (-0,56 %)     D'IETEREN GROUP 168.700 € (-2,77 %)     ARGENX SE 775.600 € (-0,79 %)     WDP 22.500 € (+0,99 %)     AB INBEV 73.900 € (+0,16 %)     UMICORE 20.620 € (-3,19 %)     AEDIFICA 71.500 € (+1,35 %)     SOFINA 215.000 € (-1,92 %)     FLUXYS BELGIUM D 20.000 € (+2,83 %)     SIPEF 93.100 € (+0,54 %)     KBC 117.500 € (-0,30 %)     UCB 255.700 € (-0,35 %)     GBL 78.550 € (-0,70 %)     CMB.TECH 12.500 € (-4,87 %)     PROXIMUS 6.110 € (0,00 %)     AGFA-GEVAERT 0.420 € (-2,10 %)     ELIA GROUP 139.500 € (-0,14 %)     VAN DE VELDE 30.100 € (-0,33 %)     TUBIZE-FIN 219.800 € (0,00 %)     AGEAS 69.500 € (+0,14 %)     CAMPINE 215.000 € (+0,47 %)     FAGRON 23.650 € (-1,25 %)     VIOHALCO 19.180 € (-1,64 %)     DEME GROUP 176.000 € (-0,79 %)     EVS 27.300 € (-2,15 %)     CARE PROPERTY INV. 12.580 € (+0,32 %)     COLRUYT 35.780 € (+1,71 %)     XIOR 26.600 € (+0,76 %)     JENSEN-GROUP 82.400 € (-0,72 %)     AZELIS GROUP 9.865 € (-0,55 %)     BEKAERT 40.250 € (0,00 %)     DECEUNINCK 2.205 € (-0,68 %)     WAREHOUSES ESTATES 40.200 € (+0,75 %)     IBA 16.600 € (-0,36 %)     TESSENDERLO 19.580 € (-1,51 %)     KBC ANCORA 80.700 € (+0,37 %)     ASCENCIO 52.400 € (+0,19 %)     TITAN S.A. 52.100 € (-2,25 %)     GIMV 44.300 € (+0,11 %)     MELEXIS 76.900 € (-2,78 %)     KINEPOLIS GROUP 35.700 € (+0,14 %)     BARCO 8.345 € (-0,95 %)     MONTEA 66.700 € (+0,91 %)     CENERGY 23.740 € (-1,98 %)     CFE 13.250 € (-1,49 %)     BPOST 1.546 € (-0,90 %)     EKOPAK 3.840 € (+1,05 %)     LOTUS BAKERIES 11 400.000 € (-0,18 %)     TEXAF 40.800 € (-0,49 %)     ATENOR 1.705 € (-2,57 %)     VGP 84.000 € (-0,36 %)     BIOTALYS 3.130 € (-1,26 %)     RETAIL ESTATES 70.300 € (+0,72 %)     ONWARD MEDICAL 2.565 € (-1,91 %)     NYXOAH 1.446 € (-2,03 %)     ONTEX GROUP 2.490 € (-1,19 %)  
   FDJ UNITED 20.660 € (-3,46 %)     FERMENTALG 0.480 € (0,00 %)     MEDIANTECHNOLOGIES 4.395 € (+0,34 %)     B.COM.PORTUGUES 1.019 € (-0,49 %)     VIVORYON 1.090 € (+0,46 %)     THEON INTERNAT 30.360 € (-1,43 %)     PUBLICIS GROUPE SA 85.780 € (-0,92 %)     LVMH 490.200 € (-0,85 %)     STMICROELECTRONICS 63.290 € (-2,72 %)     SANOFI 73.670 € (-0,12 %)     STELLANTIS NV 5.003 € (-2,36 %)     DANONE 72.300 € (+3,32 %)     KERING 267.500 € (-0,15 %)     TOTALENERGIES 68.290 € (-1,41 %)     CVC CAPITAL 12.090 € (-2,34 %)     ORANGE 17.180 € (+1,03 %)     MEMSCAP REGPT 4.620 € (-1,91 %)     CLARIANE 4.188 € (-1,46 %)     GTT 179.100 € (-2,24 %)     AIRBUS 191.180 € (-2,00 %)     NEURONES 33.100 € (-2,07 %)     CAPGEMINI 86.740 € (-1,99 %)     CSG 12.238 € (-0,91 %)     EDENRED 22.020 € (-0,18 %)     ADYEN 809.300 € (-1,53 %)     AIR FRANCE -KLM 13.950 € (+0,65 %)     IMCD 80.700 € (-0,54 %)     GALP ENERGIA-NOM 18.350 € (-0,33 %)     HAFFNER ENERGY 0.217 € (-2,48 %)     ACCOR 50.500 € (-2,17 %)     WOLTERS KLUWER 55.360 € (-0,82 %)     ALTAREA 98.600 € (+0,82 %)     DASSAULT SYSTEMES 17.515 € (-0,43 %)     NN GROUP 76.120 € (-0,55 %)     ASR NEDERLAND 66.180 € (+0,21 %)     ABN AMRO BANK N.V. 36.520 € (-1,11 %)     KERLINK 1.240 € (-4,98 %)     LEGRAND 145.900 € (-1,19 %)     SHELL PLC 33.605 € (-1,28 %)     ASML HOLDING 1 570.000 € (-1,51 %)     2CRSI 26.640 € (+4,55 %)     PLUXEE 11.090 € (+0,27 %)     FUGRO 9.550 € (-4,21 %)     AHOLD DEL 35.520 € (+1,11 %)     EXOSENS 52.000 € (-1,23 %)     TOMTOM 4.532 € (-1,22 %)     SCHNEIDER ELECTRIC 279.800 € (+0,09 %)     ABIONYX PHARMA 2.015 € (-2,18 %)     CARREFOUR 16.448 € (+1,18 %)     DSM FIRMENICH AG 79.720 € (-0,97 %)     V LANSCHOT KEMPEN 64.900 € (-2,99 %)     L'OREAL 388.250 € (+0,08 %)     ENGIE 27.310 € (+0,92 %)     PROSUS 37.165 € (-1,63 %)     EUTELSAT COMMUNIC. 2.128 € (-1,48 %)     CREDIT AGRICOLE 17.600 € (-0,37 %)     PULLUP ENTERTAIN 8.050 € (+0,63 %)     ASM INTERNATIONAL 963.800 € (-2,74 %)     ALSTOM 15.505 € (-1,15 %)     ATOS GROUP 32.600 € (-2,40 %)  
News Réglementées
07/03/2023 13:56

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

The Vanguard Group, Inc. ( IRSH)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

07-March-2023 / 12:56 GMT/BST


Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

  1.         Full name of discloser

The Vanguard Group, Inc.

  1.         Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

  1.         Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Horizon Therapeutics plc

  1.         If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

  1.         Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

03 March 2023

  1.           In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security
(Note 3)

US$0.0001 ordinary shares

 

Interests

Short positions

Number

%

Number

%

  1. Relevant securities owned and/or controlled

21,327,299

9.32%

 

 

  1. Cash-settled derivatives

 

 

 

 

  1. Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

21,327,299

9.32%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit
(Note 5)

US$0.0001 ordinary shares

Purchase

478

110.05 USD

US$0.0001 ordinary shares

Sale

1,634

110.05 USD

US$0.0001 ordinary shares

Sale

4,500

110.27 USD

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

  

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 Not Applicable

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 none

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière